Related Experiment Video
Updated: Jan 18, 2026

Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
Reducing muscle weakness in nursing home residents: a study quantifying acceptance and feasibility of a formal
Jonas Böcker1, Ludwig Sachs2,3, Michael Drey4
1Institute of Aerospace Medicine, German Aerospace Center, Cologne, North-Rhine Westphalia, Germany. jonas.boecker@dlr.de.
Background:
Sarcopenia is a growing problem, especially in nursing care. It is therefore mandatory to integrate measures such as resistance training to maintain muscle strength into nursing care.
Aims:
The aim of this study was to investigate the acceptance and feasibility of a novel training algorithm in a nursing home environment. Furthermore, the reliability of measurements for the diagnosis of sarcopenia was tested in the nursing home setting.
Methods:
Twenty-eight nursing home residents took part in the study, which encompassed two pre- and two post-examinations and a four-week training intervention. The training sessions were documented with regard to acceptance and feasibility as well as training motivation and intensity.
Results:
A combined acceptance and feasibility of at least 54% was shown, quantifying adherence of the residents to the training. The operational feasibility was 91% and the exercise performance feasibility of the residents was between 88% and 94.2%. All intraclass correlation coefficients showed at least a good reliability (all ≥ 0.84). Training motivation was higher when participants trained in a group (p = 0.007), but training intensity was greater when they trained individually (p < 0.001).
Discussion:
The main influencing factors for acceptance and feasibility were illness in general and a lack of motivation by the residents. Against the assumption, training was also possible during the weekends.
Conclusions:
In conclusion, the study shows that our proposed training algorithm is acceptable and feasible in a nursing home environment. In future, the efficacy of the training needs to be shown.
Trial Registration Number:
DRKS00030211; Date of registration: 2022-09-12.

